The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 530.00
Bid: 528.00
Ask: 534.00
Change: 0.00 (0.00%)
Spread: 6.00 (1.136%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 530.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Abdulrazak Gurnah wins Nobel Prize in Literature

8 Oct 2021 08:00

RNS Number : 4786O
Bloomsbury Publishing PLC
08 October 2021
 

 

Abdulrazak Gurnah wins the 2021 Nobel Prize in Literature

 

 

Abdulrazak Gurnah, the internationally acclaimed author of ten novels including the Booker prize shortlisted Paradise and, most recently, the Orwell prize shortlisted Afterlives, has won the 2021 Nobel Prize in Literature.

Abdulrazak Gurnah said: 'I am honoured to be awarded this prize and to join the writers who have preceded me on this list. It is overwhelming and I am so proud.'

Alexandra Pringle, Executive Publisher at Bloomsbury Publishing and Abdulrazak Gurnah's long-time editor said: 'I am completely thrilled for Abdulrazak Gurnah. For years and years he has told beautiful and powerful stories of the winds of politics, trade, colonisation, love and war that blow people across continents. I have been publishing his novels since my earliest days at Bloomsbury and after twenty years of keeping the faith, this is one of the happiest days of my life.'

Born and brought up in Zanzibar, Abdulrazak Gurnah moved to the United Kingdom in 1967 to escape the violence of the state. He is the author of ten novels: Memory of Departure, Pilgrims Way, Dottie, Paradise (shortlisted for the Booker Prize and the Whitbread Award), Admiring Silence, By the Sea (longlisted for the Booker Prize and shortlisted for the Los Angeles Times Book Award), Desertion (shortlisted for a Commonwealth Writers' Prize), The Last Gift, Gravel Heart and Afterlives (shortlisted for the Orwell Prize). Former Professor of English at the University of Kent, Abdulrazak Gurnah lives in Canterbury.

 

ABOUT BLOOMSBURY: Bloomsbury Publishing is a leading independent publishing house, established in 1986, with authors who have won the Nobel, Pulitzer and Booker Prizes, and is the originating publisher and custodian of the Harry Potter series. Bloomsbury has offices in London, New York, New Delhi, Oxford and Sydney.

 

 

UK: For more information, please contact Ros Ellis at ros.ellis@bloomsbury.com

 

Hudson Sandler LLP

+44 (0) 20 7796 4133

Dan de Belder / Rebekah Chapman

bloomsbury@hudsonsandler.com

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGWCUUPGUAR
Date   Source Headline
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report
2nd Jun 202311:50 amRNSDirector/PDMR Shareholding
1st Jun 20239:34 amRNSDirector Declaration
31st May 20232:04 pmRNSInvestor Presentation
31st May 20237:00 amRNSAudited Preliminary Results
16th May 20237:00 amRNSNotice of Capital Markets Event
2nd May 20232:43 pmRNSNotice of Results
12th Apr 20233:16 pmRNSHolding(s) in Company
11th Apr 202310:03 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSTrading Update
1st Mar 20237:00 amRNSNotice of Trading Update
17th Feb 20232:09 pmRNSBLOCK LISTING SIX MONTHLY RETURN
11th Jan 20239:08 amRNSHolding(s) in Company
18th Nov 20222:29 pmRNSHolding(s) in Company
14th Nov 20225:16 pmRNSHolding(s) in Company
2nd Nov 20222:56 pmRNSDirector/PDMR Shareholding
1st Nov 20225:16 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSInvestor Presentation
27th Oct 20221:02 pmEQSBloomsbury Publishing pleased with 'surge in the numbers'
26th Oct 20227:00 amRNSUnaudited Interim Results
14th Oct 202212:41 pmRNSHolding(s) in Company
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Sep 202211:16 amRNSHolding(s) in Company
24th Aug 20225:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20224:16 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSBlock Listing Six Monthly Return
10th Aug 20225:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.